loadpatents
Patent applications and USPTO patent grants for Lundbeck; Jane Marie.The latest application filed is for "benzothiazoles having histamine h3 receptor activity".
Patent | Date |
---|---|
Heteroaryl-ureas and their use as glucokinase activators Grant RE45,183 - Murray , et al. October 7, 2 | 2014-10-07 |
Medicaments Grant 8,846,677 - Hohlweg , et al. September 30, 2 | 2014-09-30 |
Benzothiazoles having histamine H3 receptor activity Grant 8,772,285 - Dorwald , et al. July 8, 2 | 2014-07-08 |
Medicaments Grant 8,501,739 - Hohlweg , et al. August 6, 2 | 2013-08-06 |
Benzothiazoles Having Histamine H3 Receptor Activity App 20130079340 - Dorwald; Florencio Zaragoza ;   et al. | 2013-03-28 |
Benzothiazoles having histamine H3 receptor activity Grant 8,394,842 - Dorwald , et al. March 12, 2 | 2013-03-12 |
Heterocyclic H3 antagonists Grant 8,344,001 - Hohlweg , et al. January 1, 2 | 2013-01-01 |
6-(4-cyclopropylpiperazin-1-yl)-2'-methyl-[3, 4']-bipyridine and its uses as a medicament Grant 8,318,927 - Lundbeck , et al. November 27, 2 | 2012-11-27 |
Novel Medicaments App 20120232078 - Hohlweg; Rolf ;   et al. | 2012-09-13 |
Heteroaryl-ureas and their use as glucokinase activators Grant 8,263,634 - Murray , et al. September 11, 2 | 2012-09-11 |
6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine And Its Use As A Medicament App 20110071159 - Lundbeck; Jane Marie ;   et al. | 2011-03-24 |
Heteroaryl-ureas And Their Use As Glucokinase Activators App 20110060019 - Murray; Anthony ;   et al. | 2011-03-10 |
Heteroaryl-ureas and their use as glucokinase activators Grant 7,872,139 - Murray , et al. January 18, 2 | 2011-01-18 |
Heteroaryl-ureas and their use as glucokinase activators Grant 7,851,636 - Murray , et al. December 14, 2 | 2010-12-14 |
Benzothiazoles Having Histamine H3 Receptor Activity App 20100298316 - Dorwald; Florencio Zaragoza ;   et al. | 2010-11-25 |
Heterocyclic H3 Antagonists App 20100267721 - Hohlweg; Rolf ;   et al. | 2010-10-21 |
Heteroaryl-Ureas and Their Use as Glucokinase Activators App 20100204288 - Murray; Anthony ;   et al. | 2010-08-12 |
Novel Medicaments App 20090312309 - Hohlweg; Rolf ;   et al. | 2009-12-17 |
Heteroaryl-ureas and their use as glucokinase activators Grant 7,598,391 - Murray , et al. October 6, 2 | 2009-10-06 |
Heteroaryl-Ureas and Their Use as Glucokinase Activators App 20090216013 - Murray; Anthony ;   et al. | 2009-08-27 |
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV Grant 7,235,538 - Kanstrup , et al. June 26, 2 | 2007-06-26 |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 7,192,952 - Kanstrup , et al. March 20, 2 | 2007-03-20 |
Heteroaryl-ureas and their use as glucokinase activators App 20070054897 - Murray; Anthony ;   et al. | 2007-03-08 |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20050148606 - Kanstrup, Anders Bendtz ;   et al. | 2005-07-07 |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 6,869,947 - Kanstrup , et al. March 22, 2 | 2005-03-22 |
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV App 20040034014 - Kanstrup, Anders Bendtz ;   et al. | 2004-02-19 |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 6,645,995 - Kanstrup , et al. November 11, 2 | 2003-11-11 |
Hetrocyclic compounds that are inhibitors of the enzyme DPP-IV App 20030199528 - Kanstrup, Anders B. ;   et al. | 2003-10-23 |
Novel aromatic compounds App 20030186944 - Kristiansen, Marit ;   et al. | 2003-10-02 |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20030105077 - Kanstrup, Anders Bendtz ;   et al. | 2003-06-05 |
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV App 20020161001 - Kanstrup, Anders Bendtz ;   et al. | 2002-10-31 |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20020103384 - Kanstrup, Anders ;   et al. | 2002-08-01 |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 6,380,398 - Kanstrup , et al. April 30, 2 | 2002-04-30 |
New therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20010031780 - Kanstrup, Anders ;   et al. | 2001-10-18 |
4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use Grant 6,177,443 - Madsen , et al. January 23, 2 | 2001-01-23 |
Heterocyclic compounds Grant 6,046,214 - Kristiansen , et al. April 4, 2 | 2000-04-04 |
Pyrrolidine compounds useful in the treatment of diabetes Grant 5,952,363 - Kristiansen , et al. September 14, 1 | 1999-09-14 |
Heterocyclic chemistry Grant 5,834,482 - Lundbeck , et al. November 10, 1 | 1998-11-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.